Seeking Alpha3h
AbbVie: Emraclidine's Failure Eliminates An Important Growth Driver
Emraclidine's failure in phase 2 trials is a significant setback for AbbVie's neuroscience pipeline. This was a very ...
Intel admits defeat on Arrow Lake — but it’s not down for the count
Intel admits that its Core Ultra 9 285K and Core Ultra 5 245K have problems, but it plans to address the issues with a ...
The Daily Telegraph5h
Synchron boss Tom Oxley hails Donald Trump’s ‘positive impact’ on medical devices
Neuralink’s brain-computer interface ... “It’s great that Elon is focused on this problem. It’s hard to see where the ceiling ...